iShares US Pharmaceuticals ETF
IHE
IHE
95 hedge funds and large institutions have $133M invested in iShares US Pharmaceuticals ETF in 2018 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 10 increasing their positions, 43 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
95
Holders Change
-6
Holders Change %
-5.94%
% of All Funds
2.18%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
9
Increased
10
Reduced
43
Closed
15
Calls
$4.53M
Puts
$1.18M
Net Calls
+$3.35M
Net Calls Change
+$2.9M
Top Buyers
Top Sellers
1 |
Bank of America
Charlotte,
North Carolina
|
-$4.29M |
2 |
AWA
ARS Wealth Advisors
St. Petersburg,
Florida
|
-$3.14M |
3 |
UBS Group
Zurich,
Switzerland
|
-$2.84M |
4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$1.18M |
5 |
Citadel Advisors
Miami,
Florida
|
-$989K |